A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
We are honored to provide technology and services to help providers thrive, and that the HFMA panel awarded our solution Peer Review designation.
The future of life sciences is hurtling towards a digital revolution with emphasis on immediacy for the pharmaceutical, biopharmaceutical, and medical device technology value chain.
The power of RWD and RWE continues to play a key role in helping increase research efficiency and accelerate the introduction of new treatments.
Automated buying experience with complete visibility into procurement will help drive healthcare supply chain resiliency, savings opportunities and quality patient care across the care continuum.
More and more researchers are turning to actionable insights derived from the PINC AI™ Healthcare Database to further knowledge about cancer.
Premier's Karen Niven highlights the essential role of change management in successful healthcare value analysis programs.
bioMérieux and PINC AI™ Applied Sciences collaborate to understand the epidemiology, HRU and costs related to AGE in adult patients.
Premier, Inc. announced that its Board of Directors is evaluating potential strategic alternatives to enhance value for stockholders.
HFMA |
In this Executive Roundtable sponsored by Remitra®, participants discussed ways to relieve labor cost increases, inflation, declining Medicare reimbursements and clawbacks.
MedCity News |
UPMC's Patrick Flaherty and Premier's Ed Estrada highlight ways to ensure greater predictability and consistency in medical device cybersecurity management.
Premier reacts to CMS' proposed inpatient payment update and proposals to advance health equity in FY 2024.
Using data and technology to drive decisions around the right supplies, services and equipment for optimal care delivery, safety, outcomes and total cost.